Albert Morales

Grupo de investigación

Señalización hepatocelular y cáncer Group leader (R4-IIBB-CSIC)

amorales@clinic.cat 0000-0001-8702-2269

Publicaciones destacadas

Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH

Autores:
Grondal, Sturla Magnus; Tutusaus, Anna; Boix, Loreto; Reig, Maria; Blo, Magnus;

(...)

Jackson, Akil; de Frutos, Pablo Garcia; Lorens, James Bradley; Morales, Albert; Mari, Montserrat.

Referencia: Frontiers In Immunology 2024.
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma

Autores:
Tutusaus, Anna; Sanduzzi-Zamparelli, Marco; Boix, Loreto; Rider, Patricia; Subias, Silvia;

de Frutos, Pablo Garcia; Colell, Anna; Mari, Montserrat; Reig, Maria; Morales, Albert.

Referencia: Cancers 2024.
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice

Autores:
Cuno-Gomiz, Carlos; de Gregorio, Estefania; Tutusaus, Anna; Rider, Patricia; Andres-Sanchez, Nuria;

Colell, Anna; Morales, Albert; Mari, Montserrat.

Referencia: Biology Of Sex Differences 2023.
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

Autores:
Martínez-Bosch, N; Barranco, L; Manero-Rupérez, N; Moreno, M; Navarro, P;

(...)

Visa, L; Jiménez-Parrado, S; Guerra, C; Earl, J; Carrato, A.

Referencia: Ebiomedicine 2022.
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species

Autores:
Cucarull, Blanca; Tutusaus, Anna; Hernaez-Alsina, Tania; Garcia de Frutos, Pablo; Reig, Maria;

Colell, Anna; Mari, Montserrat; Morales, Albert.

Referencia: Antioxidants 2021.
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome

Autores:
Morales, Albert; Rojo Rello, Silvia; Cristobal, Helena; Fiz-Lopez, Aida; Arribas, Elisa;

(...)

de la Cal-Sabater, Paloma; Nicolaes, Gerry A F; Ortiz-Perez, Jose T; Bernardo, David; Garcia de Frutos, Pablo.

Referencia: Biomedicines 2021.
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models

Autores:
Cucarull, Blanca; Tutusaus, Anna; Subias, Miguel; Stefanovic, Milica; Hernaez-Alsina, Tania;

(...)

Garcia de Frutos, Pablo; Mari, Montserrat; Colell, Anna; Bruix, Jordi; Morales, Albert.

Referencia: Cancers 2020.
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target

Autores:
Tutusaus, Anna; de Gregorio, Estefania; Cucarull, Blanca; Cristobal, Helena; Areste, Cristina;

(...)

Gausdal, Gro; Lorens, James B; de Frutos, Pablo Garcia; Morales, Albert; Mari, Montserrat.

Referencia: Cmgh Cellular And Molecular Gastroenterology And Hepatology 2020.
Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress

Autores:
de Dios, Cristina; Bartolessis, Isabel; Roca-Agujetas, Vicente; Barbero-Camps, Elisabet; Mari, Montserrat;

Morales, Albert; Colell, Anna.

Referencia: Redox Biology 2019.
Orthoxenografts of testicular germ cell tumors demonstrate genomic changes associated with cisplatin resistance and identify PDMP as a re-sensitizing agent.

Autores:
Piulats, Josep M; Vidal, August; Garcia-Rodriguez, Francisco J; Munoz, Clara; Nadal, Marga;

(...)

Morales, Albert; Vinals, Francesc; Garcia-del-Muro, Xavier; Ceron, Julian; Villanueva, Alberto.

Referencia: Clinical Cancer Research 2018.

Proyectos destacados

The interplay between ACE2 and AXL systems to predict COVID-19 disease severity and outcomes.

Investigador/a principal: Albert Morales Munoz

Código: 202133-32

Duración: 01/10/2021 - 31/12/2024
TERAPIAS MOLECULARES DIRIGIDAS AL MICROAMBIENTE EN FIBROSIS Y CANCER

Investigador/a principal: Albert Morales Munoz

Código: RTI2018-095672-B-I00

Duración: 01/01/2019 - 30/06/2022

Albert Morales

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

The interplay between ACE2 and AXL systems to predict COVID-19 disease severity and outcomes.

TERAPIAS MOLECULARES DIRIGIDAS AL MICROAMBIENTE EN FIBROSIS Y CANCER

Suscríbete a la Newsletter del Clínic